Black Rock Inc. Rapt Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,472,153 shares of RAPT stock, worth $7.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,472,153

Previous 2,453,049 0.78%

Holding current value

$7.54 Million

Previous $61 Million 63.58%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$6.87 - $26.45 $131,244 - $505,300	19,104 Added 0.78%	2,472,153 $22.2 Million
Q4 2023 Feb 13, 2024	BUY	$11.28 - $25.46 $1.51 Million - $3.42 Million	134,236 Added 5.79%	2,453,049 $61 Million
Q3 2023 Nov 13, 2023	BUY	$16.34 - $24.66 $2.36 Million - $3.56 Million	144,369 Added 6.64%	2,318,813 $38.5 Million
Q2 2023 Aug 11, 2023	BUY	$16.06 - $21.61 $44,004 - $59,211	2,740 Added 0.13%	2,174,444 $40.7 Million
Q1 2023 May 12, 2023	BUY	$17.19 - $30.8 $4.61 Million - $8.26 Million	268,179 Added 14.09%	2,171,704 $39.9 Million

Q4 2022 Feb 13, 2023	SELL	$16.28 - $24.6 $2.59 Million - $3.91 Million	-159,134 Reduced 7.71%	1,903,525 $37.7 Million
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $109,124 - $185,074	6,076 Added 0.3%	2,062,659 $49.6 Million
Q2 2022 Aug 12, 2022	BUY	$10.26 - $23.59 $2.61 Million - $6.01 Million	254,723 Added 14.14%	2,056,583 $37.5 Million
Q1 2022 May 12, 2022	BUY	$17.02 - $40.22 $6,654 - $15,726	391 Added 0.02%	1,801,860 $39.6 Million
Q4 2021 Feb 10, 2022	SELL	$29.5 - $39.5 $2.87 Million - $3.85 Million	-97,352 Reduced 5.13%	1,801,469 $66.2 Million
Q3 2021 Nov 09, 2021	BUY	$29.86 - $39.47 $8.66 Million - $11.5 Million	290,159 Added 18.04%	1,898,821 $59 Million
Q2 2021 Aug 11, 2021	BUY	$17.99 - $40.02 $28.9 Million - $64.4 Million	1,608,662 New	1,608,662 $51.1 Million

Others Institutions Holding RAPT

# of Institutions

148

Shares Held

29.2M

Call Options Held

709K

Put Options Held

1.06M

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $90.5M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account